RIC is a privately-owned European center of excellence for analytical solutions and has been supporting industries and government agencies in various markets for over 35 years. Founded by Professor Pat Sandra in 1986 and currently led by his two sons Tom and Koen Sandra, RIC’s core values of scientific know-how and technical expertise have resulted in a strong analytical offering for its customers, particularly in the field of chromatography, electrophoresis and mass spectrometry. RIC has taught some of the greatest thinkers in the world of separation sciences with many industry-thought leaders accrediting them as ‘the place where they got started’. Under its brand name "RIC biologics" the company delivers in-depth product understanding to the pharmaceutical and biotechnological industry, from early development, across clinical testing and after commercialization. RIC brings to the table its broad product experience in large biological molecules (NBEs, biosimilars, mAbs, mAb fragments, ADCs, bi-/multi-specifics, enzymes, DNA/RNA, LNP’s, cell-based products and complex formulations, e.g. vaccines) and small synthetic compounds (NCEs, generics, peptides, oligo’s).

Our analytical activities include:

• Lead selection & formulation


• Method development


• Identification & characterization


• Quantification


• Stability & comparability testing


• Training & consultancy


• Root-cause investigations


• ... and much more

Sounds like something for YOU? Connect with Thomas Martens (BD & Sales Manager – Team Lead) and Pieter-Paul Stybol (Account Manager) at booth no. 55.

Can’t wait to speak to us at the event? Reach out directly via our contact form.

Can't wait? Visit us online! Our website Our LinkedIn page